1. Home
  2. News

News

Milestone 1000 patients in trials Anticancer Fund

More than 1.000 patients participating in Anticancer Fund clinical trials

On International Clinical Trials Day, we’ve reached a milestone: more than 1.000 patients are participating in our 7 ongoing clinical trials across 31 countries. These numbers represent more than data — they represent progress, and lives. Discover how smart research is driving change.

Brain tumour in children - U-R-Immune Glioma trial by Anticancer Fund

New clinical trial targets aggressive brain tumours in children and young adults

We started a global trial, U-R-Immune Glioma, investigating whether Immune therapy can offer an alternative treatment for children and young adults with brain tumours. In collaboration with SickKids and CHEO in Canada.

Drug Repurposing as a Source of Innovative Therapies in Cervical Cancer

Presented at the European Society of Gynaecological Oncology Annual Conference 2021 in Prague

How to capture real-world data to prove efficacy of repurposed drugs?

METRO-PD1: A Phase I Feasibility Study Evaluating Anti-PD1 (NIVOLUMAB) In Combination With Metronomic Chemotherapy In Children And Teenagers With Refractory/Relapsing Solid Tumors Or Lymphoma

Presented at SIOP 2021 Congress

Clinical research in surgical oncology matters